- Home
- COEP vs MLEC Comparison
COEP vs MLEC Comparison
Compare COEP & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- MLEC
- Stock Information
- Founded
- COEP 2017
- MLEC 2008
- Country
- COEP United States
- MLEC Luxembourg
- Employees
- COEP N/A
- MLEC N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- MLEC Blank Checks
- Sector
- COEP Health Care
- MLEC Finance
- Exchange
- COEP Nasdaq
- MLEC Nasdaq
- Market Cap
- COEP 32.4M
- MLEC 23.9M
- IPO Year
- COEP N/A
- MLEC N/A
- Fundamental
- Price
- COEP $12.45
- MLEC $0.68
- Analyst Decision
- COEP
- MLEC
- Analyst Count
- COEP 0
- MLEC 0
- Target Price
- COEP N/A
- MLEC N/A
- AVG Volume (30 Days)
- COEP 111.8K
- MLEC 12.6K
- Earning Date
- COEP 03-25-2025
- MLEC 03-12-2025
- Dividend Yield
- COEP N/A
- MLEC N/A
- EPS Growth
- COEP N/A
- MLEC N/A
- EPS
- COEP N/A
- MLEC N/A
- Revenue
- COEP N/A
- MLEC $5,625,124.00
- Revenue This Year
- COEP N/A
- MLEC $20.42
- Revenue Next Year
- COEP N/A
- MLEC $30.00
- P/E Ratio
- COEP N/A
- MLEC N/A
- Revenue Growth
- COEP N/A
- MLEC 521.53
- 52 Week Low
- COEP $2.31
- MLEC $0.53
- 52 Week High
- COEP $13.70
- MLEC $3.25
- Technical
- Relative Strength Index (RSI)
- COEP 63.21
- MLEC 44.84
- Support Level
- COEP $8.65
- MLEC $0.53
- Resistance Level
- COEP $12.95
- MLEC $0.78
- Average True Range (ATR)
- COEP 1.64
- MLEC 0.05
- MACD
- COEP -0.16
- MLEC -0.01
- Stochastic Oscillator
- COEP 75.25
- MLEC 49.68
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About MLEC Moolec Science SA
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.